These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1921546)

  • 1. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor and zidovudine in the treatment of neutropenia and human immunodeficiency virus infection.
    Hewitt RG; Morse GD
    Pharmacotherapy; 1992; 12(6):455-61. PubMed ID: 1492010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of zidovudine].
    Mulder JW
    Ned Tijdschr Geneeskd; 1995 Feb; 139(5):211-3. PubMed ID: 7854480
    [No Abstract]   [Full Text] [Related]  

  • 5. Zidovudine in asymptomatic HIV infection.
    Phillips AN; Sabin CA
    N Engl J Med; 1993 Dec; 329(25):1895; author reply 1895-6. PubMed ID: 8247049
    [No Abstract]   [Full Text] [Related]  

  • 6. Zidovudine: clinical experience in symptomatic HIV disease.
    Fischl MA
    AIDS Clin Rev; 1989; ():221-42. PubMed ID: 2488693
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatments of human immunodeficiency virus infection. Current developments].
    Sereni D; Rousseau F
    Ann Med Interne (Paris); 1991; 142(3):209-14. PubMed ID: 1649566
    [No Abstract]   [Full Text] [Related]  

  • 9. [Resistance to azidothymidine in human immunodeficiency virus (HIV) infection].
    Karmanov EV; Lukashov VV
    Mol Biol (Mosk); 1994; 28(1):7-20. PubMed ID: 7511784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 11. Zidovudine and human immunodeficiency virus-associated peripheral neuropathies: low intake in patients with mononeuropathy multiplex and no evidence for neurotoxicity.
    Lefaucheur JP; Authier FJ; Verroust J; Gherardi RK
    Muscle Nerve; 1997 Jan; 20(1):106-9. PubMed ID: 8995592
    [No Abstract]   [Full Text] [Related]  

  • 12. AZT resistance in isolates of HIV.
    Richman DD
    Immunodefic Rev; 1991; 2(4):315-8. PubMed ID: 2059436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drug treatment for HIV/AIDS.
    Goldschmidt RH; Moy A
    Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early zidovudine and survival in HIV infection.
    Gail MH; Mark SD
    N Engl J Med; 1992 Sep; 327(11):815; author reply 815-6. PubMed ID: 1472233
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
    Moreno García M; Fernández González F
    Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
    [No Abstract]   [Full Text] [Related]  

  • 16. Early zidovudine and survival in HIV infection. The Veterans Affairs AIDS Cooperative Studies Group.
    Hartigan PM; Hamilton JD; Simberkoff MS
    N Engl J Med; 1992 Sep; 327(11):814-5; author reply 815-6. PubMed ID: 1501668
    [No Abstract]   [Full Text] [Related]  

  • 17. Zidovudine (AZT) for treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice.
    Colson ER; Horwitz RI; Bia FJ; Viscoli CM
    Arch Intern Med; 1991 Apr; 151(4):709-13. PubMed ID: 2012453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.
    Erice A; Mayers DL; Strike DG; Sannerud KJ; McCutchan FE; Henry K; Balfour HH
    N Engl J Med; 1993 Apr; 328(16):1163-5. PubMed ID: 8455683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
    Ugeskr Laeger; 1993 Jan; 155(2):104-7. PubMed ID: 8421854
    [No Abstract]   [Full Text] [Related]  

  • 20. Late treatment of HIV infection--is it better?
    Hamilton JD
    Infect Agents Dis; 1992 Jun; 1(3):156-62. PubMed ID: 1365540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.